Vir Biotechnology, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $1.70B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $48.0M | 2.8% |
| Other Investing | $794.0M | 46.8% |
| Other | $351.5M | 20.7% |
| Net Cash Flow | $504.6M | 29.7% |
Net Cash Flow Breakdown
Total Cash from Operations: $1.70B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $48.0M | 2.8% |
| Other Investing | $794.0M | 46.8% |
| Other | $351.5M | 20.7% |
| Net Cash Flow | $504.6M | 29.7% |